Universal Health Services (NYSE:UHS - Get Free Report) had its price target lowered by equities research analysts at Stephens from $235.00 to $205.00 in a report issued on Wednesday,MarketScreener reports. The brokerage currently has an "equal weight" rating on the health services provider's stock. Stephens' price objective points to a potential upside of 20.92% from the stock's previous close.
Several other research analysts also recently issued reports on UHS. Barclays dropped their target price on shares of Universal Health Services from $268.00 to $238.00 and set an "overweight" rating on the stock in a research note on Tuesday. Zacks Research downgraded shares of Universal Health Services from a "strong-buy" rating to a "hold" rating in a research report on Monday, March 2nd. Robert W. Baird decreased their price objective on shares of Universal Health Services from $241.00 to $204.00 and set a "neutral" rating for the company in a report on Wednesday. Weiss Ratings cut Universal Health Services from a "buy (b-)" rating to a "hold (c+)" rating in a research report on Friday, April 17th. Finally, Raymond James Financial downgraded Universal Health Services from an "outperform" rating to a "market perform" rating in a research note on Wednesday. Six investment analysts have rated the stock with a Buy rating, eleven have issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the stock currently has a consensus rating of "Hold" and an average price target of $216.88.
Read Our Latest Analysis on UHS
Universal Health Services Price Performance
Shares of NYSE:UHS opened at $169.53 on Wednesday. Universal Health Services has a 1-year low of $152.33 and a 1-year high of $246.32. The company has a debt-to-equity ratio of 0.55, a current ratio of 1.05 and a quick ratio of 0.98. The business has a fifty day moving average price of $190.23 and a 200-day moving average price of $209.21. The company has a market capitalization of $10.36 billion, a PE ratio of 7.06, a PEG ratio of 0.82 and a beta of 1.29.
Universal Health Services (NYSE:UHS - Get Free Report) last announced its quarterly earnings results on Monday, April 27th. The health services provider reported $5.62 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $5.36 by $0.26. Universal Health Services had a net margin of 8.56% and a return on equity of 19.78%. The company had revenue of $4.50 billion for the quarter, compared to analysts' expectations of $4.39 billion. During the same quarter in the previous year, the business posted $4.84 EPS. Universal Health Services's revenue was up 9.6% compared to the same quarter last year. Universal Health Services has set its FY 2026 guidance at 22.640-24.520 EPS. As a group, equities analysts expect that Universal Health Services will post 23.4 EPS for the current fiscal year.
Institutional Investors Weigh In On Universal Health Services
Hedge funds have recently added to or reduced their stakes in the stock. Elyxium Wealth LLC bought a new position in shares of Universal Health Services during the 4th quarter valued at $25,000. Harbor Capital Advisors Inc. purchased a new stake in Universal Health Services during the fourth quarter valued at $26,000. SBI Securities Co. Ltd. increased its position in Universal Health Services by 320.0% during the third quarter. SBI Securities Co. Ltd. now owns 126 shares of the health services provider's stock valued at $26,000 after acquiring an additional 96 shares during the last quarter. Founders Capital Management bought a new position in Universal Health Services in the fourth quarter valued at about $28,000. Finally, Root Financial Partners LLC bought a new position in Universal Health Services in the third quarter valued at about $28,000. 86.05% of the stock is currently owned by hedge funds and other institutional investors.
Key Headlines Impacting Universal Health Services
Here are the key news stories impacting Universal Health Services this week:
- Positive Sentiment: UHS beat Q1 estimates: reported $5.62 EPS vs. $5.36 consensus and $4.50B revenue vs. $4.39B est; revenue rose ~9.6% YoY and management set FY‑2026 EPS guidance at $22.64–$24.52 — core results and guidance helped support the stock. Yahoo: Earnings Call Summary
- Positive Sentiment: Behavioral health admissions and patient‑day growth were a key driver of the top‑line beat, offsetting some higher operating costs — this segment strength is a positive earnings takeaway for medium‑term revenue stability. Zacks: Q1 Earnings Beat
- Neutral Sentiment: Full earnings call transcript and detail are available for investors who want management color on volumes, pricing and expense cadence; useful for modeling out margin recovery. Seeking Alpha: Q1 Call Transcript
- Neutral Sentiment: Longer‑term value case highlighted by Zacks — low valuation metrics (relative to peers), strong ROE and steady cash flow make UHS a candidate for value‑oriented portfolios, though timing depends on operational execution. Zacks: Value Stock Analysis
- Negative Sentiment: TD Cowen cut its price target to $230 from $245 but kept a Buy — the lower target trims upside expectations despite maintaining a positive view. Benzinga: TD Cowen PT Cut
- Negative Sentiment: Deutsche Bank trimmed its PT to $230 (from $261) while keeping a Buy — another pullback in analyst targets that can pressure sentiment. MarketScreener: Deutsche Bank PT Cut
- Negative Sentiment: RBC lowered its price target to $190 from $216 and moved to Sector Perform — a more cautious stance that reduces analyst‑driven upside. MarketScreener: RBC PT Cut
- Negative Sentiment: Robert W. Baird trimmed its target to $204 (from $241) and moved to Neutral — another sign that brokers are lowering near‑term expectations even as some retain positive ratings. Benzinga: Baird PT Cut
About Universal Health Services
(
Get Free Report)
Universal Health Services, Inc NYSE: UHS is one of the largest diversified health care management companies in the United States, offering a broad spectrum of services through its acute care hospital and behavioral health segments. The company operates general acute care hospitals, surgical hospitals and ambulatory centers, as well as inpatient and outpatient behavioral health facilities. Its network provides emergency and specialized medicine, diagnostic imaging, laboratory services, advanced surgical care and rehabilitation, complemented by a comprehensive array of behavioral services including psychiatric treatment, addiction programs and developmental disabilities care.
In the acute care segment, UHS's facilities deliver services ranging from emergency department treatment and intensive care to maternity care and outpatient surgery.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Universal Health Services, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Universal Health Services wasn't on the list.
While Universal Health Services currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2026 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.